Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kiora Pharmaceuticals, Inc. (KPRX) vs Phio Pharmaceuticals Corp. (PHIO)

Kiora Pharmaceuticals, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Phio Pharmaceuticals Corp. are of similar size ($12.4M and $11.8M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against 79.0%. Across the 15 metrics below, Kiora Pharmaceuticals, Inc. leads on 11 and Phio Pharmaceuticals Corp. on 4.

Valuation

Metric KPRX PHIO Biotechnology median
P/E n/m n/m 7.88
P/S 0.87 86.27 11.47
P/B 0.96 0.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.05 0.09 0.74
EV/Sales (0.03) (9.03) 10.73
Earnings yield (94.06%) (127.72%) (28.84%)
Free cash flow yield (53.02%) (104.03%) (23.03%)

Profitability

Metric KPRX PHIO Biotechnology median
Gross margin 85.06% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (113.71%) (57.72%)
Return on assets (39.43%) (100.78%) (49.22%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX PHIO Biotechnology median
Revenue growth (TTM) 983.73% 78.95% 5.64%
EPS growth (last fiscal year) (403.45%) 84.03% —
Revenue growth, 5-year CAGR 88.72% (21.62%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 8.39 4.73
Net debt to EBITDA 1.33 2.28 0.96

Dividend

Metric KPRX PHIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KPRX PHIO Biotechnology median
Market cap 11.81m 12.43m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack